This page is research and education. It is not medical advice, a dose chart, or a reason to start anything on your own. TB-500 listed by research vendors is typically labeled Research Use Only. FLX Peptides is not a pharmacy.
If you want a 1-on-1 conversation after you read this, book a consult.
What people mean by TB-500
Thymosin beta-4 is a naturally occurring peptide involved in cell movement and tissue-repair conversations in the research literature. TB-500 is the name most research vendors and forums use for a synthetic fragment related to that molecule.
Those two names get used as if they were identical. They are not always the same object on a COA. If a listing says TB-500, the report should name the actual sequence or fragment, not just the nickname.
It is not a steroid. It is not an FDA-approved drug you pick up under the name TB-500 at a retail pharmacy. Most public literature is preclinical. Anyone selling it as a settled, approved recovery therapy is overselling it.
Why people search it
The search pattern is almost always recovery: muscle, tendon, ligament, and "systemic repair" language. It often shows up next to BPC-157 as the other half of what people call a Wolverine stack.
Interest is not proof. Preclinical work has looked at actin binding, cell migration, and injury models. That is the research context. It is not a guarantee of what happens in a person, and it is not a protocol.
People also search TB-500 because a friend, a coach, or a podcast treated it as the "whole-body" peptide and BPC-157 as the "local" one. That split is a forum story. It is not a rule you should treat as settled science.
How it differs from BPC-157 in the conversation
Keep this at the conversation level, not a ranking.
- BPC-157 searches cluster around gut, local injury, and a gastric-origin story.
- TB-500 / thymosin beta-4 searches cluster around cell movement and more "systemic" recovery talk.
- Vendors often sell them as a blend. A blend is two identity problems, not one.
If you are evaluating a blend, each compound needs a lot-matched COA. One PDF for "Wolverine" with no sequences is a flyer.
For the BPC-157 side of that pairing, read BPC-157: The Complete Research Guide.
What a source check looks like
The checklist does not change because the nickname is popular.
- The COA names the compound or fragment and matches the lot on the vial.
- There is a method (typically HPLC, often mass spec for identity), not only a purity percentage.
- The lab is a real third party you can look up.
- The date fits that lot.
- The vendor can say Research Use Only in writing.
Red flags: recycled COA images, identical purity on every batch, no company identity, "pharmaceutical grade" with no pharmacy, sold for human use in the headline and research-only in the footer.
A fuller walkthrough is How to Evaluate a Peptide Source.
How coaching helps
Better You FLX coaching is 1-on-1 with Josh in Penn Yan, NY. The point is not a secret dose. The point is to slow the decision down: what you are actually trying to solve, what belongs with a clinician, and whether a listing is even evaluable.
We do not publish prescription-style TB-500 protocols on this page.
Research use, not medical advice
Nothing here is a diagnosis, a dose, or permission to use a research chemical in a person. TB-500 / thymosin beta-4 research materials are Research Use Only unless you are working with a licensed prescriber and a lawful pharmacy product.
Questions also go through Contact. Phone: 315-359-1527.
Book a consult
If you want a plain conversation about TB-500, thymosin beta-4, or how it gets discussed next to BPC-157, book a 1-on-1 consult with Better You FLX.
https://www.flxpeptides.com/consult